标题
Brivaracetam: a novel antiepileptic drug for focal-onset seizures
作者
关键词
-
出版物
Therapeutic Advances in Neurological Disorders
Volume 11, Issue -, Pages 175628561774208
出版商
SAGE Publications
发表日期
2017-11-23
DOI
10.1177/1756285617742081
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
- (2017) Jerome Niquet et al. EPILEPSIA
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis
- (2017) Christian Brandt et al. EPILEPSY & BEHAVIOR
- Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals
- (2017) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
- (2017) Rik Schoemaker et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The adverse event profile of brivaracetam: A meta-analysis of randomized controlled trials
- (2017) Li-na Zhu et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey
- (2017) Bernhard J. Steinhoff et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy
- (2016) Sheridan M. Hoy CNS DRUGS
- Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy
- (2016) Pavel Klein et al. EPILEPSIA
- Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus
- (2016) Armel Stockis et al. EPILEPSIA
- Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
- (2016) Manuel Toledo et al. EPILEPSIA
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration
- (2016) Armel Stockis et al. EPILEPSY RESEARCH
- Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies
- (2016) Martin J. Brodie et al. EPILEPSY RESEARCH
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
- (2016) Elinor Ben-Menachem et al. NEUROLOGY
- Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs
- (2016) Francesco Brigo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies
- (2015) Reetta Kälviäinen et al. EPILEPSIA
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam augments short-term depression and slows vesicle recycling
- (2015) Xiaofeng Yang et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Brivaracetam and carbamazepine interaction in healthy subjects and in vitro
- (2015) Armel Stockis et al. EPILEPSY RESEARCH
- The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies
- (2015) Xin Tian et al. EXPERT OPINION ON PHARMACOTHERAPY
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
- (2014) Isabelle Niespodziany et al. CNS Neuroscience & Therapeutics
- Brivaracetam Single and Multiple Rising Oral Dose Study in Healthy Japanese Participants: Influence of CYP2C19 Genotype
- (2014) Armel Stockis et al. Drug Metabolism and Pharmacokinetics
- Interaction between brivaracetam (100 mg/day) and a combination oral contraceptive: A randomized, double-blind, placebo-controlled study
- (2014) Armel Stockis et al. EPILEPSIA
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Brivaracetam Disposition in Mild to Severe Hepatic Impairment
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
- (2012) Wim Van Paesschen et al. EPILEPSIA
- Patterns of treatment response in newly diagnosed epilepsy
- (2012) M. J. Brodie et al. NEUROLOGY
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial
- (2010) J. A. French et al. NEUROLOGY
- The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
- (2008) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy
- (2007) Rafal M. Kaminski et al. NEUROPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started